Alasdair Coles
Drs Scolding and Wiebe rehearse the usual arguments around physician-assisted death, with familiar themes (the "slippery slope," right to autonomy, impact on palliative care) on which most readers will already have formed views. Disappointingly, neither identifies issues specifically relevant to people with multiple sclerosis (MS) contemplating euthanasia.
First, compared to many other diseases for which physician-assisted death is requested, MS has a long disease course, with an uncertain prospect of many years of advanced disability and dependence, and a poor societal image. This leads to relatively high rates of depression, anxiety, and suicidal thoughts, including among people with modest disability. Respondents to requests for euthanasia from people early in MS will have to carefully judge the relative weights of physical and psychiatric morbidity, and how realistically the patient is viewing their future. For similar reasons, physicians should be wary of advance directives written early in the disease course which may only come into effect decades later; evidence from people with shorter illnesses suggests they may change their view when actually experiencing advanced disease. Second, it is difficult to predict the progression of disability in MS at an individual level. In regions, such as Oregon, where physician-assisted death is only legal for those facing limited life expectancy, it would be hard to confidently declare someone with MS eligible until they had extreme disability. Third, in most situations where people with MS are physically unable to take their own lives (and therefore reliant on physician-assisted suicide), they are likely to have significant cognitive impairment and communication difficulties. This makes the assessment of intent, capacity, and mood challenging. It would also effectively exclude most people with MS from euthanasia in regions where substitute decision makers are not permitted.
The complexity of these issues should mean that the advice of MS experts is sought when someone with the disease requests physician-assisted death (although in practice this often does not happen).
The number of regions which permit physicianassisted suicide is steadily growing. I predict that MS neurologists in those areas will encounter a steady low rate of requests from their patients for euthanasia. As individuals, we should prepare our emotional, professional, and ethical reaction. As a community of patients, carers, and physicians, we need to think carefully through some disease-specific issues.
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